Samsung Medison, a global medical equipment company affiliated with Samsung Electronics, has acquired Sonio, a leading medtech firm focused on women’s and children’s health. This acquisition, valued at €85 million and recently approved by the French Ministry of the Economy and Finance, represents a significant milestone in expanding Sonio's innovative AI-powered healthcare solutions worldwide. Sonio's technology, which enhances the quality and efficiency of obstetrics and gynecology ultrasound exams, has gained recognition for its role in improving prenatal care.
Sonio, founded in 2020, has made substantial progress in developing AI-driven tools for maternal and child health, securing FDA clearance and deploying its solutions across multiple sites in the United States. The acquisition by Samsung Medison will enable Sonio to integrate its advanced technology into Samsung's ultrasound roadmap while maintaining its commitment to supporting all ultrasound device manufacturers. Sonio's CEO, Cécile Brosset, emphasized the company’s ongoing mission to provide equal access to high-quality maternal healthcare globally, even as it continues its commercial growth independently.
Samsung Medison's CEO, Kyu Tae Yoo, highlighted the importance of Sonio’s real-time ultrasound exam guidance and quality assurance in addressing workforce shortages in the global healthcare industry. By combining Sonio's AI technology with Samsung's engineering expertise, the partnership aims to introduce next-generation innovations that will enhance exam quality, efficiency, and overall patient care. The acquisition underscores the growing significance of AI in overcoming healthcare challenges, particularly in the field of maternal and child health.
Click here to read the original news story.